课题基金 / 基金详情

ARC Training Centre for Personalised Therapeutics Technologies

ARC Training Centre for Personalised Therapeutics Technologies
ARC 个性化治疗技术培训中心
批准号:
IC170100016
负责人:
Prof Alastair Stewart
金额:
$217.59万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Industrial Transformation Training Centres
财政年份:
2018
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2018-05-11 至 2024-12-31

项目摘要

项目成果

Prof Alastair Stewart的其他基金

相似基金

相关文献

中文摘要
翻译
ARC个人化治疗技术培训中心旨在创造和开发技能和技术,以受益于细胞/芯片上器官技术将对医药技术/制药行业产生的变革性影响。通过将基于微流体的/实时技术与个性化药物相结合,培训中心将通过改进对潜在疗法的筛选,提供行业增长机会。使用单个患者的细胞和分子研究结果最终将使个性化诊断和治疗决策成为可能。
英文摘要
The ARC Training Centre for Personalised Therapeutics Technologies aims to create and develop the skills and technology to benefit from the transformative impacts that cell/organ-on-a-chip technology will have on the medtech/pharma industries. By combining microfluidics-based/real-time technologies with personalised medicine the Training Centre will provide industry growth opportunities through improved screening of potential therapeutics. The use of an individual patient’s cellular and molecular research findings will ultimately enable personalised diagnostic and therapeutic decisions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Steroid-enhancing selective casein kinase inhibitors: first in class novel inhaled anti-asthma agents
  • 批准号:
    nhmrc : 1137171
  • 项目类别:
    Development Grants
  • 资助金额:
    $36.38万
  • 财政年份:
    2018
  • 负责人:
    Prof Alastair Stewart
  • 依托单位:
How does bronchoconstriction worsen asthma?
  • 批准号:
    nhmrc : 1145332
  • 项目类别:
    Project Grants
  • 资助金额:
    $71.99万
  • 财政年份:
    2018
  • 负责人:
    Prof Alastair Stewart
  • 依托单位:
Transforming drug screening technology
  • 批准号:
    LP160100635
  • 项目类别:
    Linkage Projects
  • 资助金额:
    $38.39万
  • 财政年份:
    2016
  • 负责人:
    Prof Alastair Stewart
  • 依托单位:
Glucocorticoid resistance: identifying new anti-inflammatory drug targets
  • 批准号:
    nhmrc : 628691
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $30.23万
  • 财政年份:
    2010
  • 负责人:
    Prof Alastair Stewart
  • 依托单位:
海外基金